Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Brentuximab Vedotin in Early Diffuse Cutaneous Systemic Sclerosis

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
antineoplastic-agentssystemic-sclerosis
diffuse cutaneous systemic sclerosis, systemic sclerosis, scleroderma, brentuximab vedotin, cd30-directed antibody-drug conjugate, antirheumatic agents, antineoplastic agents, connective tissue diseases, skin diseases, immunologic factors, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 847714
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.